Efficacy of LCS compared with manual techniques

Article

Cost remains a large disadvantage to femtosecond laser cataract surgery

Femtosecond laser technology

The advancement in Femtosecond lasers has been remarkable, though debate continues about whether to become involved with the technology based on clinical efficacy and safety. The Catalys laser (Optimedica, Sunnyvale, California, USA) that our practice acquired in April 2012 has since had multiple upgrades - in particular improving power efficiency and accuracy. The most recent upgrade has reduced anterior capsulotomy time to less than 2 seconds, provided corneal incisions and dramatically reduced lens fragmentation times as well as enhancing the treatment zone. These improvements highlight that this technology has not yet reached maturity.

Another safety feature of the platform is the liquid optics interface, which causes only a small and transient rise in IOP.1 This is important for our elderly cataract patients who have significant co-morbidities such as glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.